The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of ipatasertib in combination with pembrolizumab for first-line treatment of recurrent or metastatic squamous cell cancer of the head and neck.
 
Jacob Stephen Thomas
Consulting or Advisory Role - Kura Oncology; Tasly Pharmaceuticals
 
Justine Yang Bruce
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - Kura Oncology; Lilly; Merck
Research Funding - Astellas Pharma (Inst); Incyte (Inst); Kura Oncology (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
 
Zujun Li
No Relationships to Disclose
 
Jochen H. Lorch
No Relationships to Disclose
 
Tanyanika Phillips
No Relationships to Disclose
 
Victoria Villaflor
No Relationships to Disclose
 
Christopher Ruel
No Relationships to Disclose
 
Joycelynne Palmer
No Relationships to Disclose
 
J. Silvio Gutkind
Stock and Other Ownership Interests - I09 LLC; Kadima Pharmaceuticals; Pangea Therapeutics Ltd
Consulting or Advisory Role - Domain Therapeutics; I09 LLC; Ono Pharmaceutical; Pangea Therapeutics Ltd.
Research Funding - Dracen (Inst); Kura Oncology (Inst); Revolution Medicines (Inst); Springworks Therapeutics (Inst); Verastem (Inst)
 
Miguel Angel Villalona-Calero
Stock and Other Ownership Interests - Moderna Therapeutics
Consulting or Advisory Role - Lilly
Speakers' Bureau - Amgen
Research Funding - Amgen - Local PI (Inst); cyclacel local PI (Inst); Hummingbird local PI (Inst); IDEAYA local PI (Inst); Kronos- local PI (Inst); Zenshine local PI (Inst)
 
Alexander Dimitrios Colevas
Consulting or Advisory Role - Alpha BioCom; Beigene; ClearView Healthcare Partners; Deallus; Galera Therapeutics; Gilead Sciences; InhibRx; leidos biomedical research; McGivney Global Advisors
Research Funding - Abbvie; Abbvie; adpnp; AstraZeneca; Atara Biotherapeutics; BioNtech; BioNTech SE; BMS; Cellsight Technologies; CUE Biopharma; Cullinan Oncology; Exelixis; Experimental Therapeutics Clinical Trials Network (ETCTN); Forty Seven; Gilead Sciences; Incyte; Incyte; Incyte; Innate Pharma; Merck; NIH/NCI; NRG Oncology; Replimune; Tessa Therapeutics; Threshold Pharmaceuticals; Viracta Therapeutics